Harbin Electric(01133.HK) was included in Stock Connect on September 7. Southbound holdings increased to 10.022 million shares as of October 16, representing 1.47% of H share capital, more than double the 4.63 million shares held on the first day of inclusion. Revenue for the first half of 2026 was RMB24.799 billion, up 10.35% year on year, and net profit attributable to owners of the parent was RMB1.718 billion, up 63.47%.
ASMPT (00522.HK) fell 3.62% to HKD 133.000; its CFO joined the board on 19 October and advanced packaging is set to top 50% of the OSAT market in 2026.
XIAOMI-W (01810.HK) rose 1.50% to HKD 27.060; China's H1 humanoid robot output topped 40,000 units and 18 measures were issued to boost embodied AI in commerce.
On 20 October 2026, TRANSCENTA-B (06628.HK) received RMB 95 million net of tax as first payment for its CDMO asset sale worth RMB 190 million.
On 20 October 2026, CHINA LILANG (01234.HK) reported a high single-digit rise in third-quarter 2026 LILANZ retail sales value from a year earlier.
On 20 October 2026, VIRTUAL MIND (01520.HK) said DolphinOne 2.0, its AI creation and agent platform, is now available globally on the Apple App Store.
On 20 October 2026, QUNABOX GROUP (00917.HK) said six shareholders, including chairwoman Yin Juehui, will not sell 103,161,396 shares for 12 months.
On 20 October 2026, OCUMENSION-B (01477.HK) said its OT-101 Phase III trial met the China primary endpoint at month 36, with myopia progression below placebo.
On 19 October 2026, NANHUA FUTURES (02691.HK) said its unit's RMB 55 million fund subscription, or 3.33% of capital, completed registration and filing.
On 20 October 2026, INSILICO (03696.HK) said its AI drug discovery collaboration with Servier reached an early milestone, triggering an undisclosed payment.
On 20 October 2026, BBMG (02009.HK) said its unit signed an agreement on 16 October to return three Chongqing plots covering 139,187 sq m for RMB 1.948 billion.
On 20 October 2026, EBENVIRONMENT (00257.HK) said it had completed a RMB 2 billion 2026 third tranche medium-term note issue in China at a 1.50% coupon.
On 20 October 2026, ASCLETIS-B (01672.HK) reported positive preclinical data for weekly oral peptide pipeline, with ASC36o showing a 7-day half-life in monkeys.
On 20 October 2026, DSBJ (02384.HK) began a global offering of 113,783,200 H shares, with 11,378,400 in Hong Kong, at up to HKD 93.80, listing on 28 October.
On 20 October 2026, XTALPI (02228.HK) said chairman Wen Shuhao bought 3,793,000 shares, or 0.09% of issued shares, for about HKD 25 million in 7-15 October.
On 20 October 2026, Changzhou Microintelligence (03275.HK) began a global offering of 37,275,800 H shares at HKD 16.63 to 21.46, listing on 28 October 2026.
